Ohio Xarelto Lawyers
The Ohio Pharmaceutical Injury Attorneys at Clark, Perdue & List are investigating claims for personal injury and death arising from use of Xarelto.
Xarelto (“Rivaroxaban”) is one of the newest prescription anticoagulants on the market. This dangerous drug, manufactured by Bayer and marketed in the United Stated by Janssen Pharmaceuticals, a Johnson & Johnson subsidiary, is already nearing “blockbuster” status with projected sales exceeding $1 billion by the end of 2014. Since its FDA approval in 2011, numerous cases of serious bleeding events, cerebral hemorrhages, strokes, blood clots and heart attacks have been reported. In 2012 – the second year Xarelto was on the market – the U.S. FDA reported 151 deaths and 2,081 serious complications associated with Xarelto. In just the first quarter of 2013, nearly 700 adverse complications were reported.
All blood thinning medications create a risk of excess bleeding. But learn more about why the bleeding risk with Xarelto can be more dangerous than with Warfarin.
Many medical professionals have expressed concern about Xarelto’s safety. Like Pradaxa, another blood thinner, there is no antidote for uncontrolled bleeding caused by Xarelto.
A Xarelto lawsuit, involving hundreds of consumers, is ongoing.